ETON PHARMACEUTICALS INC (ETON) Stock Analyst Ratings
USA - NASDAQ:ETON - US29772L1089 - Common Stock
19.14 USD
-0.11 (-0.57%)
18.55 USD
-0.59 (-3.08%)
ChartMill assigns a Buy % Consensus number of 82% to ETON. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 30.6. This target is 59.87% above the current price.
ETON was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about ETON.
In the previous month the buy percentage consensus was at a similar level.
ETON was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-16 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2025-05-14 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-03-19 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2025-03-19 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-10 | B. Riley Securities | Initiate | Buy |
| 2025-01-08 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-01-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-28 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-10-04 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-10-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-06 | Craig-Hallum | Initiate | Buy |
| 2023-12-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-21 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-09-26 | HC Wainwright & Co. | Maintains | Buy |
| 2022-07-25 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-17 | HC Wainwright & Co. | Maintains | Buy |
ETON PHARMACEUTICALS INC / ETON FAQ
Can you provide the average price target for ETON PHARMACEUTICALS INC stock?
9 analysts have analysed ETON and the average price target is 30.6 USD. This implies a price increase of 59.87% is expected in the next year compared to the current price of 19.14.
What is the consensus rating for ETON PHARMACEUTICALS INC (ETON) stock?
The consensus rating for ETON PHARMACEUTICALS INC (ETON) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed ETON PHARMACEUTICALS INC (ETON)?
The number of analysts covering ETON PHARMACEUTICALS INC (ETON) is 9.